Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects
Condition(s):Systemic Lupus ErythematosusLast Updated:May 6, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Systemic Lupus ErythematosusLast Updated:May 6, 2016Completed
Condition(s):CD22+ Relapsed/Refractory B-ALLLast Updated:January 19, 2017Withdrawn
Condition(s):Systemic Lupus ErythematosusLast Updated:May 12, 2015Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:October 3, 2018Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:July 12, 2012Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:July 12, 2012Completed
Condition(s):Non Hodgkin’s Lymphoma; NHL; Aggressive NHL; Diffuse Large B-cell LymphomaLast Updated:August 18, 2021Withdrawn
Condition(s):LymphomaLast Updated:July 6, 2016Completed
Condition(s):Lupus Erythematosus, SystemicLast Updated:April 3, 2012Terminated
Condition(s):Systemic Lupus ErythematosusLast Updated:September 28, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.